conditional

Belite Bio Announces UKs Medicines and Healthcare Products Regulatory Agency Agrees to Conditional Marketing Authorization Application Based on Interim Analysis Results for the Treatment of Stargardt Disease with Tinlarebant

November 02, 2025 09:00 ET  | Source: Belite Bio, Inc MHRA response is based on the Phase 3 DRAGON interim…

3 weeks ago

Update on the Simplified Tender Offer and Squeeze-out on NHOA

No Conditional Price Supplement PayableTAIPEI, Taiwan--(BUSINESS WIRE)--Reference is made to the simplified tender offer (the Offer) and squeeze-out transaction completed…

6 months ago